Research

Mixed

Fecal Microbiota Transplantation (FMT) restores gut homeostasis and achieves higher recovery rates (90-94%) for Clostridium difficile infection (CDI) compared to standard antibiotic therapy (vancomycin, 60% recovery) by re-establishing colonization resistance via secondary bile acid production.

If you suffer from recurrent C. difficile infection, ask your doctor about Fecal Microbiota Transplantation (FMT). Clinical data shows it restores gut diversity and achieves higher recovery rates (up to 94%) compared to standard antibiotics like vancomycin (60%). It works by reintroducing healthy bacteria that produce secondary bile acids to inhibit C. difficile growth.

GoodSupportsHIGH confidence
Patients received FMT showed long-lasting elevation of fecal microbial diversity and a high recovery rate (90%) compared to vancomycin (narrow-spectrum antibiotic) therapy (recovery rate = 60%)... Similar study by Konturek et al. (2016) also had demonstrated a high healing rate (94%) of CDI post FMT treatment, with no recurrent CDI observed across 16 months follow-up.
Zhi Y. Kho et al. · Frontiers in Microbiology · 2018

Why this rating

Cites specific clinical studies (van Nood 2013, Konturek 2016) with clear outcome metrics, though it is a review of these studies.

Source

The Human Gut Microbiome – A Potential Controller of Wellness and Disease

Zhi Y. Kho et al. · Frontiers in Microbiology · 2018

DOI 10.3389/fmicb.2018.01835

narrative_reviewCited 1,089×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →